Understanding OUR Cytokine-Based Immunotherapy Candidates Our commitment extends to advancing a robust portfolio of programs geared toward expanding the horizons of cytokine-based immunotherapy, especially for cancers where treatment options remain limited. Use the links below to learn a lot more about our portfolio of cytokine-based immunotherapy candidates. Check out https://financefeeds.com/european-fintech-faces-challenges-amidst-regulatory-and-funding-concerns/